Department of Research Methods and Diagnostics in Education, International University of La Rioja, UNIR, Logroño, La Rioja, Spain.
Department of Research Methods and Diagnostics in Education, University of Valencia, UVEG, Av. de Blasco Ibáñez, 30, 46010, Valencia, Spain.
Arch Sex Behav. 2023 Aug;52(6):2503-2526. doi: 10.1007/s10508-023-02572-z. Epub 2023 Mar 10.
Drug use before or during sex is a high-risk sexual behavior associated with adverse health risks and outcomes, such as increasing the likelihood of overdoses and of acquiring sexually-transmitted diseases. This systematic review and meta-analysis of three scientific databases examined the prevalence of the use of intoxicating substances, those tending to excite or stupefy the user on a psychoactive level, before or during sex, among young adults (18-29 years old). A total of 55 unique empirical studies met the inclusion criteria (48,145 individuals; 39% males), were assessed for risk of bias using the tools of Hoy et al. (2012), and were analyzed via a generalized linear mixed-effects model. The results produced a global mean prevalence of this sexual risk behavior of 36.98% (95% CI: 28.28%, 46.63%). Nonetheless, significant differences were identified between different intoxicating substances, with the use of alcohol (35.10%; 95% CI: 27.68%, 43.31%), marijuana (27.80%; 95% CI: 18.24%, 39.92%), and ecstasy (20.90%; 95% CI: 14.34%, 29.45%) significantly more prevalent than that of cocaine (4.32%; 95% CI: 3.64%, 5.11%), heroin (.67%; 95% CI: .09%, 4.65%), methamphetamine (7.10%; 95% CI: 4.57%, 10.88%), and GHB (6.55%; 95% CI: 4.21%, 10.05%). Moderator analyses showed that the prevalence of alcohol use before or during sex differed according to geographical sample origin, and increased as the proportion of ethnic whites in samples increased. The remaining demographic (e.g., gender, age, reference population), sexual (e.g., sexual orientation, sexual activity), health (e.g., drug consumption, STI/STD status), methodological (e.g., sampling technique), and measurement (e.g., timeframe) variables that were examined did not moderate prevalence estimates. Implications for sexual development interventions were discussed.
在性行为之前或期间使用毒品是一种高风险的性行为，与不良健康风险和后果相关，例如增加过量用药和获得性传播疾病的可能性。这项对三个科学数据库的系统回顾和荟萃分析检查了在年轻人（18-29 岁）中，性行为之前或期间使用令人兴奋或麻醉的致醉物质（即具有精神活性的物质）的流行率。共有 55 项独特的实证研究符合纳入标准（48145 人；39%为男性），使用 Hoy 等人的工具（2012 年）评估了偏倚风险，并通过广义线性混合效应模型进行了分析。结果得出，这种性行为风险的全球平均流行率为 36.98%（95%CI：28.28%，46.63%）。然而，不同致醉物质之间存在显著差异，酒精（35.10%；95%CI：27.68%，43.31%）、大麻（27.80%；95%CI：18.24%，39.92%）和摇头丸（20.90%；95%CI：14.34%，29.45%）的使用率明显高于可卡因（4.32%；95%CI：3.64%，5.11%）、海洛因（.67%；95%CI：.09%，4.65%）、冰毒（7.10%；95%CI：4.57%，10.88%）和 GHB（6.55%；95%CI：4.21%，10.05%）。调节分析表明，性行为之前或期间使用酒精的流行率因地理样本来源而异，并随着样本中白种人比例的增加而增加。其余的人口统计学（例如，性别、年龄、参考人群）、性（例如，性取向、性活动）、健康（例如，药物使用、性传播感染/性传播疾病状况）、方法学（例如，抽样技术）和测量（例如，时间框架）变量并未调节流行率估计值。讨论了对性行为发展干预的影响。
